T1	Pharmacological_substance 9 18	Phenytoin
N1000 	Reference T1 MeSH:D010672	Phenytoin
N1001 	Reference T1 MeSH:D010672	Phenytoin
T2	Disorder 27 43	hypersensitivity
N1 	Reference T2 UMLS:C0020517	hypersensitivity
T3	Pharmacological_substance 66 75	phenytoin
N1002 	Reference T3 MeSH:D010672	phenytoin
T4	Disorder 84 93	hepatitis
N2 	Reference T4 UMLS:C0019158	hepatitis
T5	Disorder 99 112	mononucleosis
N3 	Reference T5 UMLS:C0021345	mononucleosis
T7	Pharmacological_substance 156 165	phenytoin
N1003 	Reference T7 MeSH:D010672	phenytoin
T8	Disorder 166 182	hypersensitivity
N4 	Reference T8 UMLS:C0020517	hypersensitivity
T9	Disorder 262 278	seizure disorder
N5 	Reference T9 UMLS:C0014544	seizure disorder
T10	Disorder 311 317	nausea
N6 	Reference T10 UMLS:C0027497	nausea
T11	Disorder 319 327	vomiting
N7 	Reference T11 UMLS:C0042963	vomiting
T12	Disorder 329 334	fever
N8 	Reference T12 UMLS:C0015967	fever
T13	Disorder 336 351	lymphadenopathy
N9 	Reference T13 UMLS:C0497156	lymphadenopathy
T14	Disorder 381 410	left-upper-quadrant tendernes
T15	Disorder 417 429	hepatomegaly
N10 	Reference T15 UMLS:C0019209	hepatomegaly
T16	Pharmacological_substance 449 465	phenytoin sodium
N1004 	Reference T16 MeSH:D010672	phenytoin sodium
T18	Pharmacological_substance 478 491	carbamazepine
N1005 	Reference T18 MeSH:D002220	carbamazepine
T20	Disorder 576 586	leukopenia
N11 	Reference T20 UMLS:C0023530	leukopenia
T21	Pharmacological_substance 588 597	Phenytoin
N1006 	Reference T21 MeSH:D010672	Phenytoin
T22	Pharmacological_substance 641 650	phenytoin
N1007 	Reference T22 MeSH:D010672	phenytoin
T23	Disorder 676 696	tonic-clonic seizure
N12 	Reference T23 UMLS:C0494475	tonic-clonic seizure
T24	Disorder 735 777	swelling of the face and legs and pruritus
T25	Disorder 835 849	hepatotoxicity
N13 	Reference T25 UMLS:C0348754	hepatotoxicity
N14 	Reference T25 UMLS:C0235378	hepatotoxicity
T26	Disorder 877 885	comatose
N15 	Reference T26 UMLS:C0009421	comatose
T27	Disorder 887 895	Seizures
N16 	Reference T27 UMLS:C0036572	Seizures
T28	Pharmacological_substance 914 922	diazepam
N1008 	Reference T28 MeSH:D003975	diazepam
T29	Pharmacological_substance 1023 1032	primidone
N1009 	Reference T29 MeSH:D011324	primidone
T30	Pharmacological_substance 1050 1059	phenytoin
N1010 	Reference T30 MeSH:D010672	phenytoin
T31	Disorder 1060 1076	hypersensitivity
N17 	Reference T31 UMLS:C0020517	hypersensitivity
T32	Disorder 1154 1158	rash
N18 	Reference T32 UMLS:C0015230	rash
T33	Disorder 1164 1179	lymphadenopathy
N19 	Reference T33 UMLS:C0497156	lymphadenopathy
T34	Disorder 1196 1210	hepatic injury
N20 	Reference T34 UMLS:C0160390	hepatic injury
T35	Disorder 1212 1226	Encephalopathy
N21 	Reference T35 UMLS:C0085584	Encephalopathy
T36	Disorder 1231 1236	death
N22 	Reference T36 UMLS:C1306577	death
T37	Pharmacological_substance 1272 1281	phenytoin
N1011 	Reference T37 MeSH:D010672	phenytoin
T38	Disorder 1282 1298	hypersensitivity
N23 	Reference T38 UMLS:C0020517	hypersensitivity
T40	Pharmacological_substance 1466 1479	phenobarbital
N1012 	Reference T40 MeSH:D010634	phenobarbital
T41	Pharmacological_substance 1484 1497	carbamazepine
N1013 	Reference T41 MeSH:D002220	carbamazepine
T42	Pharmacological_substance 1536 1550	anticonvulsant
N1014 	Reference T42 MeSH:D000927	anticonvulsant
T43	Pharmacological_substance 1579 1588	phenytoin
N1015 	Reference T43 MeSH:D010672	phenytoin
T44	Disorder 1589 1605	hypersensitivity
N24 	Reference T44 UMLS:C0020517	hypersensitivity
T45	Pharmacological_substance 1661 1670	phenytoin
N1016 	Reference T45 MeSH:D010672	phenytoin
T46	Disorder 1707 1712	fever
N25 	Reference T46 UMLS:C0015967	fever
T47	Disorder 1714 1718	rash
N26 	Reference T47 UMLS:C0015230	rash
T48	Disorder 1724 1739	lymphadenopathy
N27 	Reference T48 UMLS:C0497156	lymphadenopathy
T19	Subject 210 233	23-year-old black woman
T49	Disorder 353 379	diffuse maculopapular rash
N28 	Reference T49 UMLS:C0015230	diffuse maculopapular rash
T53	Coreferring_mention 431 434	She
T57	Disorder 1147 1151	Feve
T58	Subject 1642 1650	patients
T62	Disorder 1128 1145	hepatic syndromes
T63	Disorder 1101 1113;1136 1145	dermatologic syndromes
N29 	Reference T63 UMLS:C0039082	dermatologic syndromes
T64	Disorder 1115 1123;1136 1145	lymphoid syndromes
T65	Speculation_cue 1087 1090	may
T39	Disorder 1307 1333	antigen-antibody reactions
T60	Disorder 1335 1368	alteration of lymphocyte function
T66	Disorder 1377 1395	enzyme abnormality
